Novavax on track to deliver Operation Warp Speed promise

Novavax is on track to deliver 100 million doses of COVID-19 vaccine NVX-CoV2373 to the U.S. by year-end, according to remarks made Tuesday by President of R&D Gregory Glenn.

Novavax Inc. (NASDAQ:NVAX) committed to the doses via its deal with Operation Warp Speed, which itself has committed to delivering 300 million doses of COVID-19 vaccines by year-end (see “Novavax Contract from Operation Warp Speed”; “Operation Warp Speeds Takes First Step”)...